Literature DB >> 29371777

Pre-micro RNA-499 Gene Polymorphism rs3746444 T/C is Associated with Susceptibility to Rheumatoid Arthritis in Egyptian Population.

Shaimaa A Fattah1, Maivel H Ghattas2, Samy M Saleh1, Dina M Abo-Elmatty1.   

Abstract

Pre-miRNA-499 gene is associated with autoimmune disease. Mir-449 rs3746444 polymorphism is inconsistent for rheumatoid arthritis (RA). This study aimed to investigate association of mir-499 rs3746444 polymorphism with RA activity and severity in Egyptian population. The study population was conducted as case control study in 100 RA patients diagnosed according to the American College of Rheumatology classification criteria for RA, and the control group included 100 healthy subjects who were age-and sex-matched to the RA group. Different genotypes were assessed using polymerase chain reaction-restriction fragment length polymorphism. 95% Confidence interval and odds ratio were defined to assess the strength of association. Regarding patients, thirty-three patients carried TT genotype, fifty-three patients carried TC genotype and fourteen patients carried CC genotype. So the frequency of the minor C allele in RA patients was significantly higher than the control subjects (P = 0.037). TC, CC genotypes and C allele frequencies were significantly associated with disease severity as they had high rheumatoid factor (55.78 µIU/ml) and anti-cyclic citrullinated peptide (Anti-CCP) antibody (297.32 µIU/ml). Moreover, the heterozygote TC had more severe and more active form of the disease compared with homozygote CC or TT as they had high Anti-CCP antibody, and disease activity score 28 (score 5). Our work suggests that C allele of Pre-miRNA rs3746444 polymorphism contributes to heritability of susceptibility to RA compared to T allele. This polymorphism was associated with the activity and severity of the disease.

Entities:  

Keywords:  MicroRNA-499; Polymerase chain reaction–restriction fragment length polymorphism; Rheumatoid arthritis; rs3746444 polymorphism

Year:  2017        PMID: 29371777      PMCID: PMC5766468          DOI: 10.1007/s12291-017-0652-7

Source DB:  PubMed          Journal:  Indian J Clin Biochem        ISSN: 0970-1915


  28 in total

1.  Infliximab and methotrexate in the treatment of rheumatoid arthritis. Anti-Tumor Necrosis Factor Trial in Rheumatoid Arthritis with Concomitant Therapy Study Group.

Authors:  P E Lipsky; D M van der Heijde; E W St Clair; D E Furst; F C Breedveld; J R Kalden; J S Smolen; M Weisman; P Emery; M Feldmann; G R Harriman; R N Maini
Journal:  N Engl J Med       Date:  2000-11-30       Impact factor: 91.245

2.  2010 rheumatoid arthritis classification criteria: an American College of Rheumatology/European League Against Rheumatism collaborative initiative.

Authors:  Daniel Aletaha; Tuhina Neogi; Alan J Silman; Julia Funovits; David T Felson; Clifton O Bingham; Neal S Birnbaum; Gerd R Burmester; Vivian P Bykerk; Marc D Cohen; Bernard Combe; Karen H Costenbader; Maxime Dougados; Paul Emery; Gianfranco Ferraccioli; Johanna M W Hazes; Kathryn Hobbs; Tom W J Huizinga; Arthur Kavanaugh; Jonathan Kay; Tore K Kvien; Timothy Laing; Philip Mease; Henri A Ménard; Larry W Moreland; Raymond L Naden; Theodore Pincus; Josef S Smolen; Ewa Stanislawska-Biernat; Deborah Symmons; Paul P Tak; Katherine S Upchurch; Jirí Vencovsky; Frederick Wolfe; Gillian Hawker
Journal:  Ann Rheum Dis       Date:  2010-09       Impact factor: 19.103

3.  Single nucleotide polymorphism associated with mature miR-125a alters the processing of pri-miRNA.

Authors:  Ranhui Duan; Changhui Pak; Peng Jin
Journal:  Hum Mol Genet       Date:  2007-03-30       Impact factor: 6.150

4.  Association of microRNA polymorphisms with the risk of myocardial infarction in a Chinese population.

Authors:  Cunrong Chen; Huashan Hong; Lianglong Chen; Xiaoyun Shi; Ying Chen; Qinyong Weng
Journal:  Tohoku J Exp Med       Date:  2014-06       Impact factor: 1.848

5.  Association of polymorphisms in pre-miRNA with inflammatory biomarkers in rheumatoid arthritis in the Chinese Han population.

Authors:  Bin Yang; Jie Chen; Yi Li; Junlong Zhang; Dongdong Li; Zhuochun Huang; Bei Cai; Lixin Li; Yunying Shi; Binwu Ying; Lanlan Wang
Journal:  Hum Immunol       Date:  2011-10-12       Impact factor: 2.850

6.  The diagnostic properties of rheumatoid arthritis antibodies recognizing a cyclic citrullinated peptide.

Authors:  G A Schellekens; H Visser; B A de Jong; F H van den Hoogen; J M Hazes; F C Breedveld; W J van Venrooij
Journal:  Arthritis Rheum       Date:  2000-01

7.  Comparative analysis of the mouse and human peptidylarginine deiminase gene clusters reveals highly conserved non-coding segments and a new human gene, PADI6.

Authors:  Stéphane Chavanas; Marie-Claire Méchin; Hidenari Takahara; Akira Kawada; Rachida Nachat; Guy Serre; Michel Simon
Journal:  Gene       Date:  2004-04-14       Impact factor: 3.688

Review 8.  Common gene polymorphisms, cancer progression and prognosis.

Authors:  Alexandre Loktionov
Journal:  Cancer Lett       Date:  2004-05-10       Impact factor: 8.679

Review 9.  Advances in the genetics of rheumatoid arthritis point to subclassification into distinct disease subsets.

Authors:  Annette H M van der Helm-van Mil; Tom W J Huizinga
Journal:  Arthritis Res Ther       Date:  2008-03-31       Impact factor: 5.156

10.  MicroRNA gene polymorphisms and environmental factors increase patient susceptibility to hepatocellular carcinoma.

Authors:  Yin-Hung Chu; Ming-Ju Hsieh; Hui-Ling Chiou; Yi-Sheng Liou; Chen-Chieh Yang; Shun-Fa Yang; Wu-Hsien Kuo
Journal:  PLoS One       Date:  2014-02-26       Impact factor: 3.240

View more
  9 in total

1.  Possible use of miRNAs-146a and -499 expression and their polymorphisms as diagnostic markers for rheumatoid arthritis.

Authors:  Ghada Ayeldeen; Yasser Nassar; Hanan Ahmed; Olfat Shaker; Tamer Gheita
Journal:  Mol Cell Biochem       Date:  2018-04-26       Impact factor: 3.396

2.  MicroRNA-499 rs3746444 polymorphism in Egyptian children with biliary atresia.

Authors:  Eman Gawish; Elhamy Abd El-Monem; Mona El-Abd; Gihan Ahmed Sobhy; Heba Ghanem
Journal:  Clin Exp Hepatol       Date:  2020-09-30

3.  An Updated Meta-Analysis of the Associations Between MicroRNA Polymorphisms and Susceptibility to Rheumatoid Arthritis.

Authors:  Mi Zhou; Bo Jiang; Mao Xiong; Xin Zhu
Journal:  Front Physiol       Date:  2018-11-15       Impact factor: 4.566

4.  Association of rs2910164 Polymorphism in miRNA-146 and rs3746444 Polymorphism in miRNA-499 with Inflammatory Arthritis: A Meta-Analysis.

Authors:  Dingjian Wang; Guixia Pan
Journal:  Biomed Res Int       Date:  2019-05-16       Impact factor: 3.411

5.  Association of microRNAs genes polymorphisms with arthritis: a systematic review and meta-analysis.

Authors:  Yingqi Xiao; Hui Liu; Li Chen; Yang Wang; Xiang Yao; Xiaolian Jiang
Journal:  Biosci Rep       Date:  2019-07-18       Impact factor: 3.840

6.  Meta-analysis of association of microRNAs genetic variants with susceptibility to rheumatoid arthritis and systemic lupus erythematosus.

Authors:  Fengzhen Liu; Yahang Liang; Yu Zhao; Lili Chen; Xiaolin Wang; Chunquan Zhang
Journal:  Medicine (Baltimore)       Date:  2021-04-30       Impact factor: 1.817

7.  Variants of MIRNA146A rs2910164 and MIRNA499 rs3746444 are associated with the development of cutaneous leishmaniasis caused by Leishmania guyanensis and with plasma chemokine IL-8.

Authors:  Tirza Gabrielle Ramos de Mesquita; José do Espírito Santo Junior; Thais Carneiro de Lacerda; Krys Layane Guimarães Duarte Queiroz; Cláudio Marcello da Silveira Júnior; José Pereira de Moura Neto; Lissianne Augusta Matos Gomes; Mara Lúcia Gomes de Souza; Marcus Vinitius de Farias Guerra; Rajendranath Ramasawmy
Journal:  PLoS Negl Trop Dis       Date:  2021-09-20

8.  Meta-Analysis of miRNA Variants Associated with Susceptibility to Autoimmune Disease.

Authors:  Jun Zhang; Handan Tan; Qingfeng Cao; Guannan Su; Peizeng Yang
Journal:  Dis Markers       Date:  2021-10-08       Impact factor: 3.434

9.  Association between miRNA-499 gene polymorphism and autoimmune diseases: A meta-analysis.

Authors:  Xiangjian Kong; Shuling Diao; Huipu Xu; Junming Sun; Baoxin Ma
Journal:  PLoS One       Date:  2022-03-31       Impact factor: 3.240

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.